Introduction & Objectives: Renal cell cancer (RCC) substantially lacks of biomarkers to assist clinicians in diagnosis, prognosis and response to therapy. Recent studies have demonstrated that the urinary proteome or peptidome is more complex than expected. The aim of this study is to compare the peptidomic profile of urine from RCC patients and healthy controls defined by Mass Spectromet
Renal cell carcinoma (RCC) represents 2.2% of all cancer incidences; however, prognostic or predicti...
Objective: To investigate discriminating protein patterns and serum biomarkers between clear cell re...
The effectiveness of treatment of renal diseases is limited because the lack of diagnostic, prognost...
INTRODUCTION AND OBJECTIVES: Up to now, for renal cell carcinoma (RCC), tumor size and growth rate ...
INTRODUCTION AND OBJECTIVES: Up to now, for renal cell carcinoma (RCC), tumor size and growth rate ...
<div><p>Renal Cell Carcinoma (RCC) is typically asymptomatic and surgery usually increases patient's...
Prostate, bladder and kidney cancer are the three most common types of genitourinary cancer in the w...
Renal Cell Carcinoma (RCC) is typically asymptomatic and surgery usually increases patient's lifespa...
Renal cell carcinoma (RCC) is typically asymptomatic and surgery usually increases patient's life on...
Renal Cell Carcinoma (RCC) is typically asymptomatic and surgery usually increases patient's lifespa...
Worldwide, over 273,000 people are diagnosed with renal cancer each year. Approximately one third of...
Background: Several promising biomarkers have been found for RCC, but none of them has been used in ...
Background: Several promising biomarkers have been found for RCC, but none of them has been used in ...
In cancer management early diagnosis is crucial for successful treatment. Unfortunately, patients mo...
OBJECTIVE: To investigate discriminating protein patterns and serum biomarkers between clear cell re...
Renal cell carcinoma (RCC) represents 2.2% of all cancer incidences; however, prognostic or predicti...
Objective: To investigate discriminating protein patterns and serum biomarkers between clear cell re...
The effectiveness of treatment of renal diseases is limited because the lack of diagnostic, prognost...
INTRODUCTION AND OBJECTIVES: Up to now, for renal cell carcinoma (RCC), tumor size and growth rate ...
INTRODUCTION AND OBJECTIVES: Up to now, for renal cell carcinoma (RCC), tumor size and growth rate ...
<div><p>Renal Cell Carcinoma (RCC) is typically asymptomatic and surgery usually increases patient's...
Prostate, bladder and kidney cancer are the three most common types of genitourinary cancer in the w...
Renal Cell Carcinoma (RCC) is typically asymptomatic and surgery usually increases patient's lifespa...
Renal cell carcinoma (RCC) is typically asymptomatic and surgery usually increases patient's life on...
Renal Cell Carcinoma (RCC) is typically asymptomatic and surgery usually increases patient's lifespa...
Worldwide, over 273,000 people are diagnosed with renal cancer each year. Approximately one third of...
Background: Several promising biomarkers have been found for RCC, but none of them has been used in ...
Background: Several promising biomarkers have been found for RCC, but none of them has been used in ...
In cancer management early diagnosis is crucial for successful treatment. Unfortunately, patients mo...
OBJECTIVE: To investigate discriminating protein patterns and serum biomarkers between clear cell re...
Renal cell carcinoma (RCC) represents 2.2% of all cancer incidences; however, prognostic or predicti...
Objective: To investigate discriminating protein patterns and serum biomarkers between clear cell re...
The effectiveness of treatment of renal diseases is limited because the lack of diagnostic, prognost...
Add to ORKG